Abstract
Objective: To evaluate the relationship between flow cytometric DNA ploidy, biological features and prognosis in patients with Stage II colorectal cancer. Methods: Nuclear DNA content, proliferation index and S-phase fraction were measured in a prospective series of 45 patients with curatively resected Stage II colorectal adenocarcinomas by means of flow cytometry using frozen tumor samples. Results: Of the 45 samples examined, 17 tumors (38%) were diploid and 28 (62%) aneuploid. The diploid tumors were significantly more common in the proximal colon than in the distal colon (67% vs. 23%; P<0.01). There was no correlation between DNA ploidy and the other clinicopathological variables (P>0.05). The proliferation index and S-phase fraction in the distal tumors were higher than those in the proximal tumors, but the difference was not significant (P>0.05). When the 5-year survival rate of patients with Stage II colorectal cancer was compared by the log rank test, a significant relationship between DNA ploidy status and disease free survival was observed in the group of all patients. Patients with DNA diploid tumors had a better disease free survival than those with DNA aneuploid tumors (P<0.05). Conclusion: These findings support that DNA ploidy status, proliferation index and S-phase fraction may differ in the proximal and distal colorectal cancer. Flow cytometric DNA ploidy status might be a useful prognostic factor in patients with Stage II colorectal cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Tang R, Ho YS, You YT, et al. Prognostic evaluation of DNA flow cytometric and histopathologic parameters of colorectal cancer [J]. Cancer 1995; 76:1724.
Bottger TC, Potratz D, Stockle M, et al. Prognostic value of DNA analysis in colorectal carcinoma [J]. Cancer 1993; 72:3579.
Visscher DW, Zarbo RJ, Ma CK, et al. Flow cytometric DNA and clinicopathologic analysis of Dukes A & B colonic adenocarcinomas: a retrospective study [J]. Mod Pathol 1990; 3:709.
Delattre O, Olschwang S, Law DG, et al. Multiple genetic alterations in distal and proximal colorectal cancer [J]. Lancet 1989; ii:353.
Lanza G Jr, Maestri I, Ballotta MR, et al. Relationship of nuclear DNA content to clinicopathologic features in colorectal cancer [J]. Mod Pathol 1994; 7:161.
Goh HS, Chan CS, Khine K, et al. p53 and behavior of colorectal cancer [J]. Lancet 1994; 344:233.
Delattre O, Olschwang S, Law DG, et al. Multiple genetic alterations in distal and proximal colorectal cancer [J]. Lancet 1989; ii:353.
Sun XF, Rutten S, Zhang H, et al. Expression of the deleted in colorectal cancer gene is related to prognosis in DNA diploid and low proliferative colorectal adenocarcinoma [J]. J Clin Oncol 1999; 17:1745.
Chapman MAS, Hardcastle JD, Armitage NCM, et al. Five-year prospective study of DNA ploidy and colorectal cancer survival [J]. Cancer 1995; 76:383.
Witzig TE, Loprinzi CI, Gonchoroff NJ, et al. DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinoma [J]. Cancer 1991; 68:879.
Bauer KD, Bagwell CB, Giaretti W, et al. Consensus review of the clinical utility of DNA flow cytometry in colorectal cancer [J]. Cytometry 1993; 14:486.
Author information
Authors and Affiliations
Corresponding author
Additional information
Biography: WANG Hong-yi (1964–), associate professor, doctor of medicine, School of Oncology, Peking University, majors in surgical oncology.
Rights and permissions
About this article
Cite this article
Wang, Hy., **, S., Xue, Zq. et al. Prognostic significance of DNA ploidy in patients with stage II colorectal cancer. Chin. J. Cancer Res. 13, 53–56 (2001). https://doi.org/10.1007/s11670-001-0013-0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11670-001-0013-0